Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-08-11Clinical Trial Update: MEK Inhibitor AZD6244 in Treating Patients With Stage III or Stage IV Melanoma [Phase 2]
A Phase 2 study of the MEK inhibitor AZD6244 (selumetinib) in patients with stage III or stage IV melanoma has completed, with results poste…
-
CLINICAL_TRIALS trial_result · 2015-08-10Clinical Trial Update: A Pharmacokinetics Study to Investigate the Effect of Vemurafenib on Digoxin in Patients With BRAFV600 Mutation-Positive Metastatic Melanoma [Phase 1]
A Phase 1 pharmacokinetics study evaluated the effect of vemurafenib on digoxin exposure in patients with BRAFV600 mutation-positive metasta…
-
CLINICAL_TRIALS trial_result · 2015-08-07Clinical Trial Update: A Study of RO5185426 in Previously Treated Melanoma Patients With Brain Metastases [Phase 2]
Phase 2 clinical trial update of RO5185426 in previously treated melanoma patients with brain metastases has completed and posted results. T…
-
CLINICAL_TRIALS trial_result · 2015-07-27Clinical Trial Update: Videoscopic Ilioinguinal Lymphadenectomy for Melanoma [NA]
A completed clinical trial evaluating videoscopic ilioinguinal lymphadenectomy for melanoma, including cases involving secondary malignant n…
-
CLINICAL_TRIALS trial_result · 2015-07-27Clinical Trial Update: Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal Cancer [Phase 2]
Phase 2 trial update for low dose naltrexone in metastatic melanoma, castration-resistant prostate cancer, and renal cancer; study terminate…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-07-08Clinical Trial Update: A Study of Intratumoral Injection of Interleukin-2 and Ipilimumab in Patients With Unresectable Stages III-IV Melanoma [Phase 1]
A Phase 1 trial evaluating intratumoral interleukin-2 in combination with ipilimumab for unresectable stage III–IV melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2015-07-07Clinical Trial Update: Ipilimumab 12-month Intensive Pharmacovigilance Protocol
This document reports the completion of a 12-month intensive pharmacovigilance protocol for ipilimumab in melanoma.
-
CLINICAL_TRIALS trial_result · 2015-06-23Clinical Trial Update: AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma [Phase 2]
A Phase 2 trial evaluating AZD2171 for recurrent or Stage IV melanoma has completed enrollment with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-06-18Clinical Trial Update: Ultraviolet Light Exposure and Immunosuppression in Cutaneous Melanoma
The clinical trial investigating ultraviolet light exposure and immunosuppression in cutaneous melanoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-06-11Clinical Trial Update: Phase 2 Study of Ipilimumab Plus Dacarbazine in Japanese Patients With Advanced Melanoma [Phase 2]
Phase 2 study evaluating ipilimumab plus dacarbazine in Japanese patients with advanced melanoma; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: CCI-779 in Treating Patients With Metastatic Melanoma [Phase 2]
This document provides an update on a Phase 2 clinical trial of CCI-779 (temsirolimus) in patients with metastatic melanoma, indicating the …
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: Feasibility and Functionality of fPAM Imaging in Melanoma
The study evaluated the feasibility and functionality of fPAM imaging in melanoma. The trial was terminated.
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: Phase 2 Study of Ipilimumab in Japanese Advanced Melanoma Patients [Phase 2]
Phase 2 study of ipilimumab in Japanese patients with advanced melanoma has completed, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-05-20Clinical Trial Update: Proof of Concept Study With an Endothelin Receptor B Inhibitor (BQ-788) for Human Melanoma [EARLY_Phase 1]
This early-phase proof-of-concept trial of the endothelin receptor B inhibitor BQ-788 for melanoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage IV Cutaneous Melanoma [Phase 1, Phase 2]
An early-phase vaccine therapy trial for stage IV cutaneous melanoma has completed Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma [Phase 1, Phase 2]
This is a Phase 1/2 clinical trial evaluating a vaccine therapy for stage III or stage IV melanoma that has completed.
-
CLINICAL_TRIALS trial_result · 2015-05-06Clinical Trial Update: Genetic Variates of Response to Cisplatin, Vinblastine, and Temozolomide (CVT) in Patients With Metastatic Melanoma [Phase 2]
Phase 2 trial assessing genetic factors that influence response to cisplatin, vinblastine, and temozolomide in metastatic melanoma; results …
-
CLINICAL_TRIALS trial_result · 2015-05-06Clinical Trial Update: Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin [Phase 1]
Phase 1 trial evaluating imiquimod with laser therapy, with or without a green dye, in patients with stage III or stage IV melanoma that has…
-
CLINICAL_TRIALS trial_result · 2015-05-06Clinical Trial Update: Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer [NA]
A completed trial compared videoscopic versus open inguinal lymphadenectomy for cancer. It includes melanoma and Merkel cell carcinoma among…
-
CLINICAL_TRIALS trial_result · 2015-05-06Clinical Trial Update: Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous Bypass
A completed clinical trial update from MD Anderson assessing inflammatory response and tissue fibrosis related to lymphatico-venous bypass a…
-
CLINICAL_TRIALS trial_result · 2015-05-01Clinical Trial Update: Everolimus in Selected Patients With Metastatic Melanoma: Efficacy and Safety Study [Phase 2]
Phase 2 trial evaluating the efficacy and safety of everolimus in selected patients with metastatic melanoma.
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Vemurafenib (R05185426) in Poor Performance Status Patients With Unresectable Locally Advanced or Metastatic Melanoma Harboring a V600E/K Mutation [Phase 2]
Phase 2 trial of vemurafenib in patients with poor performance status and unresectable locally advanced or metastatic melanoma harboring BRA…
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Interleukin-7 and Vaccine Therapy in Treating Patients With Metastatic Melanoma [Phase 1]
Phase 1 trial evaluating interleukin-7 in combination with a cancer vaccine for metastatic melanoma; the study has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Biological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer [Phase 1]
A Phase 1 trial of a biological therapy for metastatic melanoma or metastatic kidney cancer has completed its status/enrollment.
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Recurrent Metastatic Melanoma [Phase 1]
Phase 1 trial evaluating vaccine therapy with or without interleukin-2 in patients with recurrent metastatic melanoma; study completed.